Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis
Author(s) -
Lucie Le Meur,
Claire Tantet,
Minh Patrick Lê,
Emilie Desselas,
Christine Bonnal,
Agnés LilloLe Louët,
Romain Sonneville,
Laurent Massias,
Julie Giraud,
Diane Descamps,
Yazdan Yazdanpanah,
Sylvie Lariven,
Gilles Peytavin
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx495
Subject(s) - darunavir , itraconazole , histoplasmosis , ritonavir , medicine , adverse effect , virology , aids related opportunistic infections , human immunodeficiency virus (hiv) , sida , viral disease , immunology , pharmacology , dermatology , antifungal , antiretroviral therapy , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom